NYSE:EHAB

Enhabit, Inc. (NYSE:EHAB) Proposed Sale and Stock Analysis

Font: Financial Modeling Prep  • Feb 24, 2026

Market Chart
  • UBS sets a price target of $13.80 for NYSE:EHAB, indicating a potential increase of about 1.47%.
  • The proposed sale to Kinderhook Industries, LLC aligns with UBS's price target, suggesting market anticipation of the sale price.
  • EHAB's stock price has surged by 22.63%, reflecting investor optimism towards the proposed sale.

Enhabit, Inc. (NYSE:EHAB) is currently under the spotlight due to a proposed sale to Kinderhook Industries, LLC. UBS has set a price target of $13.80 for EHAB, which is slightly above its current trading price of $13.60. This suggests a potential price increase of about 1.47%, indicating a relatively stable outlook for the stock.

The proposed transaction involves Enhabit shareholders receiving $13.80 per share in cash. This aligns with UBS's price target, suggesting that the market has already factored in the potential sale price. Kahn Swick & Foti, LLC is investigating the fairness of this deal, focusing on whether the financial terms and the process are adequate for shareholders.

EHAB has seen a notable increase in its stock price, rising by 22.63%, or $2.51. This surge reflects investor optimism, possibly driven by the proposed sale. The stock's price today has ranged from $13.55 to $13.64, with the latter being its highest in the past year, indicating strong market interest.

The market capitalization of EHAB is approximately $689.4 million, reflecting the company's overall value in the stock market. With a trading volume of 12.6 million shares, there is significant activity and interest in EHAB, likely influenced by the ongoing investigation and the proposed sale.

Market Overview
TZA
Direxion Daily Small Cap Bear 3X ETF
$4.83
-7.29%
SLXN
Silexion Therapeutics Ltd.
$0.53
96.95%
HAO
Haoxi Health Technology Limited
$0.01
0.71%
SOXS
Direxion Daily Semiconductor Bear 3X ETF
$8.54
-14.00%
MEHA
Functional Brands, Inc. Common Stock
$0.09
21.95%
JUNS
Jupiter Neurosciences, Inc.
$0.21
-35.94%
PHGE
BiomX Inc.
$0.60
59.60%
WOK
WORK Medical Technology Group Ltd.
$0.19
-19.57%
HCWB
HCW Biologics Inc.
$2.43
129.25%
GDC
GD Culture Group Limited
$0.12
-17.44%